AllianceBernstein Portfolio holdings
AllianceBernstein (AB), formed in 2000 through the merger of Alliance Capital and Bernstein, is a global asset management firm headquartered in Nashville, Tennessee, managing over $759 billion in assets as of late 2024 for institutional investors, financial advisors, and individuals. Known for its research-driven approach, AB offers a diverse range of investment strategies, including equities, fixed income, alternatives, and multi-asset solutions, with a strong emphasis on active management and ESG (environmental, social, governance) integration. The firm, which relocated its headquarters from New York City to Nashville in 2021, operates globally with significant operations in New York, London, and Asia, leveraging its Bernstein Research arm for deep market insights. With a workforce of over 4,700 and a partnership structure led by CEO Seth Bernstein, AB combines a legacy of rigorous analysis with a modern focus on sustainable investing and client outcomes.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$567M |
| 2 |
Visa
V
|
+$283M |
| 3 |
CVS Health
CVS
|
+$195M |
| 4 |
Texas Instruments
TXN
|
+$188M |
| 5 |
Progressive
PGR
|
+$187M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$274M |
| 2 |
Microsoft
MSFT
|
+$263M |
| 3 |
Comcast
CMCSA
|
+$248M |
| 4 |
Amphenol
APH
|
+$238M |
| 5 |
Elevance Health
ELV
|
+$238M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.59% |
| 2 | Financials | 14.66% |
| 3 | Healthcare | 14.25% |
| 4 | Consumer Discretionary | 10.15% |
| 5 | Industrials | 10.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PMC
1926
DELISTED
PharMerica Corporation
PMC
| $1.61M | ﹤0.01% |
57,373
| – | – |
|
|
ISCA
1927
DELISTED
International Speedway Corp
ISCA
| $1.61M | ﹤0.01% |
48,059
-1,290
| -3% | -$43.7K |
|
|
MNR
1928
DELISTED
Monmouth Real Estate Investment Corp
MNR
| $1.6M | ﹤0.01% |
112,226
+18,150
| +19% | +$252K |
|
1929
Ameris Bancorp
ABCB
$5.89B
| $1.6M | ﹤0.01% |
45,754
-1,200
| -3% | -$40K |
|
|
LQ
1930
DELISTED
La Quinta Holdings Inc.
LQ
| $1.6M | ﹤0.01% |
142,960
-9,700
| -6% | -$113K |
|
|
AGR
1931
DELISTED
Avangrid, Inc.
AGR
| $1.6M | ﹤0.01% |
38,197
-500
| -1% | -$21.8K |
|
|
AJRD
1932
DELISTED
Aerojet Rocketdyne Holdings
AJRD
| $1.59M | ﹤0.01% |
90,326
-2,550
| -3% | -$46.2K |
|
1933
Adtran
ADTN
$798M
| $1.58M | ﹤0.01% |
82,753
-1,100
| -1% | -$20.3K |
|
|
FNFV
1934
DELISTED
Fidelity Natl Financial, Inc.
FNFV
| $1.58M | ﹤0.01% |
126,808
| – | – |
|
1935
TherapeuticsMD
TXMD
$23.8M
| $1.58M | ﹤0.01% |
4,647
| – | – |
|
1936
Ryanair
RYAAY
$29.5B
| $1.58M | ﹤0.01% |
52,630
-947,593
| -95% | -$27.5M |
|
1937
Safety Insurance
SAFT
$1.52B
| $1.58M | ﹤0.01% |
23,471
-500
| -2% | -$32.6K |
|
|
LMNX
1938
DELISTED
Luminex Corp
LMNX
| $1.58M | ﹤0.01% |
69,469
-1,700
| -2% | -$37K |
|
1939
Delek US
DK
$3.87B
| $1.57M | ﹤0.01% |
90,690
| – | – |
|
1940
MACOM Technology Solutions
MTSI
$20.4B
| $1.57M | ﹤0.01% |
37,000
-5,100
| -12% | -$200K |
|
|
KAMN
1941
DELISTED
Kaman Corp
KAMN
| $1.57M | ﹤0.01% |
35,654
-900
| -2% | -$39.4K |
|
|
BT
1942
DELISTED
BT Group plc (ADR)
BT
| $1.56M | ﹤0.01% |
61,466
+6,972
| +13% | +$183K |
|
|
EXPR
1943
DELISTED
Express, Inc.
EXPR
| $1.56M | ﹤0.01% |
6,623
| – | – |
|
|
XLRN
1944
DELISTED
Acceleron Pharma
XLRN
| $1.56M | ﹤0.01% |
43,150
| – | – |
|
1945
Emergent Biosolutions
EBS
$375M
| $1.56M | ﹤0.01% |
49,512
-13,300
| -21% | -$386K |
|
|
ENFC
1946
DELISTED
Entegra Financial Corp.
ENFC
| $1.56M | ﹤0.01% |
84,642
-6,776
| -7% | -$120K |
|
|
DNR
1947
DELISTED
Denbury Resources, Inc.
DNR
| $1.55M | ﹤0.01% |
481,010
-89,949
| -16% | -$275K |
|
|
NTT
1948
DELISTED
Nippon Telegraph & Telephone
NTT
| $1.55M | ﹤0.01% |
33,852
-2,298
| -6% | -$107K |
|
|
BPL
1949
DELISTED
Buckeye Partners, L.P.
BPL
| $1.54M | ﹤0.01% |
21,560
+192
| +0.9% | +$13.7K |
|
1950
iShares MSCI India ETF
INDA
$6.71B
| $1.54M | ﹤0.01% |
52,452
+5,413
| +12% | +$159K |
|
Similar funds
AllianceBernstein's Q3 2016 Portfolio in Review
As of Q3 2016, AllianceBernstein held 3,058 positions worth $118B, up 2% from $116B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
AllianceBernstein's Q3 2016 filing shows 95 new, 1,049 increased, 1,331 reduced and 82 closed positions. Its largest new stake was Teva Pharmaceuticals: 2,294,681 shares worth $106M. The largest sale was Pfizer, an estimated $274M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.
- AllianceBernstein's largest Q3 2016 buy was Teva Pharmaceuticals: 2,294,681 shares worth $106M.
- AllianceBernstein added most to State Street SPDR S&P 500 ETF Trust in Q3 2016, an estimated $567M increase.
- AllianceBernstein's biggest Q3 2016 reduction was Pfizer, cutting an estimated $274M.
- AllianceBernstein fully exited EMC CORPORATION in Q3 2016, selling an estimated $99.6M.
- AllianceBernstein's ten largest holdings make up 14% of its $118B portfolio in Q3 2016.
- AllianceBernstein opened 95 new positions and closed 82 in Q3 2016.
- AllianceBernstein's portfolio value rose 2% quarter-over-quarter to $118B.
Based on AllianceBernstein's 13F filing for Q3 2016, filed 10 Nov 2016.